Denis O'Shaughnessy, Ph.D.
Oraya Therapeutics, Inc.
2
0
1
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Emily Y Chew, M.D.
National Eye Institute (NEI)
Shared therapeutic areas:
Steven Levy, MD
MD Stem Cells
Shared therapeutic areas:
Jeffrey S Heier, MD
Ophthalmic Consultants of Boston
Shared therapeutic areas:
Alcon Investigators
Alcon Research
Shared therapeutic areas:
Novartis Customer Information
Novartis
Shared therapeutic areas:
Andrii MD Korol, PhD
The Filatov Institute of Eye Diseases and Tissue Therapy
Shared therapeutic areas:
Ahmed A Tabl, MD
Benha University
Shared therapeutic areas:
Michael Wolzt, MD
Department of Clinical Pharmacology, Medical University of Vienna
Shared therapeutic areas:
Gerhard Garhöfer, MD
Department of Clinical Pharmacology, Medical University of Vienna
Shared therapeutic areas:
Angela M Zivkovic, PhD
University of California, Davis
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD
Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
All 2 trials loaded